学 术 报 告

 

报告题目：

用于预测药物-药物间副作用的新规则和新技术

Prediction of Dug-drug Interactions,-regulatory guidance and new technologies

报 告 人：

Dr. Chuang Lu，DMPK at Millennium, The Takeda Oncology Company

报告人简介：

Dr. Chuang Lu is a Scientific Fellow in DMPK at Millennium, The Takeda Oncology Company. He received his B.S. degree in Chemistry from the Beijing University in 1982 and his Ph.D. in the Environmental Chemistry from the American University of Washington , DC in 1992.   He did his postdoctoral training at the USDA from 1992 to 1996 with emphasis on the mutagenicity of pesticides and monoclonal antibody techniques.  He then worked for the In Vitro Technologies, Inc. as a Principal Scientist and focused his research on the hepatocyte cryopreservation and application of primary cells in drug metabolism.  Dr. Lu joined Millennium in 2000 and his current research interests include drug metabolizing enzymes, drug-drug interaction, and in vitro – in vivo correlation including PBPK modeling.

 

时   间： 2013年4月23日 (星期二) 上午10:00

地   点：药理学系会议室 (生理楼二楼中厅)

 

JDB电子官方网站药理学系